top of page

London Biotechnology Show 2026 Connects Industry Buyers, Suppliers, Innovators Through Dedicated Business Programme

The London Biotechnology Show 2026 concluded at ExCeL
London after two days of industry engagement.

Image-empty-state_edited_edited.png

LONDON, November 19: The London Biotechnology Show 2026 concluded at ExCeL

London after two days of industry engagement, with its Hosted Buyer Programme and

international exhibition providing dedicated opportunities for businesses, buyers and

technology providers to explore commercial connections across the life sciences sector.


The third edition of the event brought together pharmaceutical and biotechnology

companies, research institutions, healthcare organisations, investors, manufacturers and

specialist solution providers, creating a setting for discussions around procurement,

technology adoption, partnerships and business development.


A central feature was the Hosted Buyer Programme, designed to connect qualified buyers

and senior decision-makers with participating exhibitors through pre-arranged business

meetings. The initiative aimed to facilitate focused conversations between organisations

seeking biotechnology products, services and solutions and companies offering capabilities

across the sector.


The exhibition featured a diverse range of organisations, including Merck, Thermo Fisher

Scientific, FUJIFILM Biosciences, Foxx Life Sciences, Gerresheimer, Abcam, Novogene,

Vector Laboratories, Automata and other specialist providers.


Their participation reflected the breadth of the biotechnology supply chain, encompassing

laboratory equipment, research technologies, life sciences manufacturing, diagnostics,

bioprocessing and specialist services.


The Startup Showcase added another dimension to the business programme, giving

emerging companies an opportunity to present their innovations and engage with potential

investors, buyers and strategic partners.


The event was supported by industry associations, regional innovation clusters and

professional organisations, including the BioIndustry Association, MedCity, Bionow,

BioPartner UK, Health Tech Alliance, One HealthTech, Medicon Valley Alliance, Biocat,

AseBio, Hollandbio and P-BIO.


Their involvement highlighted the importance of collaboration between businesses, research

institutions, industry networks and investment communities in strengthening the international life sciences ecosystem.


As biotechnology continues to attract investment and drive innovation across healthcare and

industrial applications, the London Biotechnology Show provided a platform for stakeholders

to identify potential areas of cooperation and explore opportunities across the global market.


The event concluded on 19 November following two days of conference sessions, exhibition

activity and business engagement.

BioFocus square logo

Author

BioFocus Newsroom

bottom of page